What Is Hemolytic Disease of the Fetus and Newborn? Hemolytic disease of the fetus and newborn (HDFN) is a blood disorder that happens when your blood type doesn't match your baby's blood type during ...

Hemolytic disease of the newborn is a type of anemia that begins during pregnancy. It can cause serious illness in a newborn, but it may be diagnosed during prenatal screening and treated to avoid ...

Nipocalimab is a fully human, anti-FcRn, aglycosylated IgG1 monoclonal antibody that reduces pathogenic alloantibodies in maternal circulation and blocks the placental transfer of maternal IgG to the ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5bqhwf/hemolytic_disease) has announced the addition of Global Markets ...

Please provide your email address to receive an email when new articles are posted on . Alloimmunization rates were 6.2% for women matched to ABO and Rhesus D and 1.9% for women also matched for c, E ...

The Food and Drug Administration (FDA) has granted Fast Track designation to nipocalimab (M281) for the prevention of hemolytic disease of the fetus and newborn (HDFN). The Food and Drug ...

Scientists have long believed that a newborn's immune system was an immature version of an adult's, but new research from Cornell University shows that newborns' T cells – white blood cells that ...

WAKEFIELD, MASS. (WHDH) - Sunday marked national day of awareness for a rare and complicated disease affecting newborn babies. And one Massachusetts family says they’re grateful their child was able ...

The stock price of Momenta Pharmaceuticals (NASDAQ: MNTA), a pharmaceutical company best known for its immunology therapies, has rallied around 26% over recent weeks (vs. about a 50% gain in the S&P ...